Status:
COMPLETED
Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)
Lead Sponsor:
Associazione Angela Serra per la ricerca sul cancro
Collaborating Sponsors:
Fondazione Italiana Linfomi - ETS
The International Non-Hodgkin Lymphoma Prognostic Factor Project
Conditions:
Lymphoma, Follicular
Eligibility:
All Genders
18+ years
Brief Summary
The F2-study is a complement of the previous studies of the Follicular Lymphoma Prognostic Factors Project which permitted the development of the Follicular Lymphoma International Prognostic Index (FL...
Detailed Description
So far, in patients with lymphoma a variety of studies aimed at the evaluation of prognosis have been conducted. In particular, different demographic, clinical and biological factors have shown a prog...
Eligibility Criteria
Inclusion
- Patients with newly diagnosed follicular lymphoma
- Patients with histologically confirmed diagnosis of follicular lymphoma according to WHO classification (any grade)
- Age over 18
- Written informed consent
Exclusion
- None
Key Trial Info
Start Date :
February 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
1093 Patients enrolled
Trial Details
Trial ID
NCT01250223
Start Date
February 1 2003
End Date
December 1 2016
Last Update
July 9 2020
Active Locations (51)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University Feinberg School of Medicine - Department of Hematology/Oncology
Chicago, Illinois, United States, 60611
2
University of Nebraska Medical Center
Omaha, Nebraska, United States, 68022
3
MD Anderson Cancer Center
Houston, Texas, United States, 77030
4
Academia Nacional de Medicina - Oncohematology Department, Instituto de Investigaciones Hematologicas
Buenos Aires, Argentina